News

Regulatory affairsRegulatory Round-up - May 2026
Filter:AllPress ReleaseCell TherapiesGene TherapiesDigital and AutomationSpin-outs, Start-ups, Sector investmentManufacturingRegulatory affairsSkills and Training
Year:All2026202520242023 →
Constructing the Cell and Gene Therapy Catapult manufacturing centreConstructing the Cell and Gene Therapy Catapult manufacturing centrePress release: Cell and Gene Therapy Catapult Licenses Cell Culture Data to Ajinomoto Co., Inc.Press release: Cell and Gene Therapy Catapult Licenses Cell Culture Data to Ajinomoto Co., Inc.Regulatory news - May 2017Regulatory news - May 2017Gene-modified T-cells: Going into battleGene-modified T-cells: Going into battleHighlights from ISCT 2017Highlights from ISCT 2017Cynata Therapeutics announce first patient treated in Phase I clinical trialCynata Therapeutics announce first patient treated in Phase I clinical trialStem cell therapies: can anything stop them now?Stem cell therapies: can anything stop them now?ReNeuron awarded major UK cell therapy manufacturing grantReNeuron awarded major UK cell therapy manufacturing grantPress release: Novel cell growth and measurement techniques unveiled at ISCT 2017Press release: Novel cell growth and measurement techniques unveiled at ISCT 2017Regulatory news - April 2017Regulatory news - April 2017Updating our clinical trials and preclinical programmes databasesUpdating our clinical trials and preclinical programmes databasesQuality by design and process automation key for making commercial cell therapiesQuality by design and process automation key for making commercial cell therapies